These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9666903)

  • 21. Punding in Parkinson's disease.
    O'Sullivan SS; Evans AH; Lees AJ
    Pract Neurol; 2007 Nov; 7(6):397-9. PubMed ID: 18024780
    [No Abstract]   [Full Text] [Related]  

  • 22. Safinamide (Xadago) for Parkinson's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1529):151-153. PubMed ID: 28880847
    [No Abstract]   [Full Text] [Related]  

  • 23. Freezing of gait in Parkinson's disease.
    Panisset M
    Neurol Clin; 2004 Oct; 22(3 Suppl):S53-62. PubMed ID: 15501366
    [No Abstract]   [Full Text] [Related]  

  • 24. The oculomotor cogwheel phenomenon and ocular bradykinesia as a manifestation of disease of extrapyramidal system (oculographic recording).
    Brzecki A; Arend R
    Pol Med J; 1970; 9(6):1463-5. PubMed ID: 5505059
    [No Abstract]   [Full Text] [Related]  

  • 25. Timing the initiation of treatment in Parkinson's disease.
    Grosset DG; Schapira AH
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):615. PubMed ID: 18487552
    [No Abstract]   [Full Text] [Related]  

  • 26. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopamine agonists, sleep disorders, and driving in Parkinson's disease.
    Uitti RJ; Wszolek ZK
    Adv Neurol; 2003; 91():343-9. PubMed ID: 12442692
    [No Abstract]   [Full Text] [Related]  

  • 28. [Urination disorders and parkinson disease].
    Blanchard-Dauphin A
    Rev Neurol (Paris); 2009 Feb; 165 Spec No 1():F5-10. PubMed ID: 19623702
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathological gambling in Parkinson's disease.
    Stocchi F
    Lancet Neurol; 2005 Oct; 4(10):590-2. PubMed ID: 16168925
    [No Abstract]   [Full Text] [Related]  

  • 30. Off and on state assessment of swallowing function in Parkinson's disease.
    Warnecke T; Hamacher C; Oelenberg S; Dziewas R
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1033-4. PubMed ID: 24997546
    [No Abstract]   [Full Text] [Related]  

  • 31. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.
    Postuma RB; Gagnon JF; Vendette M; Montplaisir JY
    Brain; 2009 Dec; 132(Pt 12):3298-307. PubMed ID: 19843648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
    Fénelon G
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Parkinson's disease and psychoses].
    Bizzarri JV; Giupponi G; Maniscalco I; Schroffenegger P; Conca A; Kapfhammer HP
    Neuropsychiatr; 2015; 29(1):1-13. PubMed ID: 25586068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's focus. Parkinson's is debilitating but new treatments are on the horizon.
    Hermanns M
    RN; 2008 Oct; 71(10):24-8; quiz 29. PubMed ID: 18942321
    [No Abstract]   [Full Text] [Related]  

  • 35. Not Parkinson's disease: neurologists' mistakes with a diversion into adult hydrocephalus.
    Jellinek EH
    Pract Neurol; 2008 Oct; 8(5):322-4. PubMed ID: 18796588
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions of sleep and Parkinson's disease.
    Razmy A; Shapiro CM
    Semin Clin Neuropsychiatry; 2000 Jan; 5(1):20-32. PubMed ID: 10704535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chewing-induced blepharospasm in Parkinson's disease.
    Spitz M; Sasse E; Vasconcellos LF; de Souza E Silva D; Pereira JS
    J Neurol Sci; 2016 Dec; 371():15-16. PubMed ID: 27871438
    [No Abstract]   [Full Text] [Related]  

  • 38. Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):112. PubMed ID: 26218794
    [No Abstract]   [Full Text] [Related]  

  • 39. 1-Hz repetitive transcranial magnetic stimulation and diphasic dyskinesia in Parkinson's disease.
    Filipović SR; Bhatia KP; Rothwell JC
    Mov Disord; 2013 Feb; 28(2):245-6. PubMed ID: 23144006
    [No Abstract]   [Full Text] [Related]  

  • 40. Parkinson's disease following panic disorder.
    Matsui H; Udaka F; Oda M; Tamura A; Kubori T; Nishinaka K; Kameyama M
    J Neuropsychiatry Clin Neurosci; 2006; 18(1):130. PubMed ID: 16525084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.